Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 64

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Biomaterials Loaded with Growth Factors/Cytokines and Stem Cells for Cardiac Tissue Regeneration

Smagul, Saltanat, Kim, Yevgeniy, Smagulova, Aiganym, Raziyeva, Kamila, Nurkesh, Ayan, Saparov, Arman·2020·International Journal of Molecular Sciences

Abstract

Myocardial infarction causes cardiac tissue damage and the release of damage-associated molecular patterns leads to activation of the immune system, production of inflammatory mediators, and migration of various cells to the site of infarction. This complex response further aggravates tissue damage by generating oxidative stress, but it eventually heals the infarction site with the formation of fibrotic tissue and left ventricle remodeling. However, the limited self-renewal capability of cardiomyocytes cannot support sufficient cardiac tissue regeneration after extensive myocardial injury, thus, leading to an irreversible decline in heart function. Approaches to improve cardiac tissue regeneration include transplantation of stem cells and delivery of inflammation modulatory and wound healing factors. Nevertheless, the harsh environment at the site of infarction, which consists of, but is not limited to, oxidative stress, hypoxia, and deficiency of nutrients, is detrimental to stem cell survival and the bioactivity of the delivered factors. The use of biomaterials represents a unique and innovative approach for protecting the loaded factors from degradation, decreasing side effects by reducing the used dosage, and increasing the retention and survival rate of the loaded cells. Biomaterials with loaded stem cells and immunomodulating and tissue-regenerating factors can be used to ameliorate inflammation, improve angiogenesis, reduce fibrosis, and generate functional cardiac tissue. In this review, we discuss recent findings in the utilization of biomaterials to enhance cytokine/growth factor and stem cell therapy for cardiac tissue regeneration in small animals with myocardial infarction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21175952

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 124

  1. McClellan, 2019, Call to action, urgent challenges in cardiovascular disease, a presidential advisory from the American Heart Association, Circulation, 139, e44, 10.1161/CIR.0000000000000652 · DOI · Paper page
  2. Swirski, 2018, Cardioimmunology: The immune system in cardiac homeostasis and disease, Nat. Rev. Immunol., 18, 733, 10.1038/s41577-018-0065-8 · DOI · Paper page
  3. Saparov, 2017, Role of the immune system in cardiac tissue damage and repair following myocardial infarction, Inflamm. Res., 66, 739, 10.1007/s00011-017-1060-4 · DOI
  4. Andreadou, 2019, Immune cells as targets for cardioprotection, new players and novel therapeutic opportunities, Cardiovasc. Res., 115, 1117, 10.1093/cvr/cvz050 · DOI · Paper page
  5. Hashimoto, 2018, Therapeutic approaches for cardiac regeneration and repair, Nat. Rev. Cardiol., 15, 585, 10.1038/s41569-018-0036-6 · DOI · Paper page
  6. Formiga, 2016, Cardiac regeneration using growth factors, advances and challenges, Arq. Bras. Cardiol., 107, 271
  7. Zaghdoudi, 2016, Pro-and anti-inflammatory cytokines in post-infarction left ventricular remodeling, Int. J. Cardiol., 221, 632, 10.1016/j.ijcard.2016.07.073 · doi:10.1016/j.ijcard.2016.07.073
  8. Ferrini, 2019, Toward regeneration of the heart, bioengineering strategies for immunomodulation, Front. Cardiovasc. Med., 6, 26, 10.3389/fcvm.2019.00026 · DOI
  9. Garbayo, 2015, Heart regeneration after myocardial infarction using synthetic biomaterials, J. Control. Release, 203, 23, 10.1016/j.jconrel.2015.02.009 · DOI
  10. Rocker, 2020, Injectable Polymeric Delivery System for Spatiotemporal and Sequential Release of Therapeutic Proteins To Promote Therapeutic Angiogenesis and Reduce Inflammation, ACS Biomater. Sci. Eng., 6, 1217, 10.1021/acsbiomaterials.9b01758 · DOI
  11. Dormont, 2018, Nanoplumbers, biomaterials to fight cardiovascular diseases, Mater. Today, 21, 122, 10.1016/j.mattod.2017.07.008 · DOI
  12. Nurkesh, 2020, Recent Advances in the Controlled Release of Growth Factors and Cytokines for Improving Cutaneous Wound Healing, Front. Cell Dev. Biol., 8, 638, 10.3389/fcell.2020.00638 · DOI
  13. Saludas, 2017, Hydrogel based approaches for cardiac tissue engineering, Int. J. Pharm., 523, 454, 10.1016/j.ijpharm.2016.10.061 · DOI
  14. Mihic, 2015, A Conductive Polymer Hydrogel Supports Cell Electrical Signaling and Improves Cardiac Function after Implantation into Myocardial Infarct, Circulation, 132, 772, 10.1161/CIRCULATIONAHA.114.014937 · DOI · Paper page
  15. Wang, 2018, An injectable conductive hydrogel encapsulating plasmid DNA-eNOs and ADSCs for treating myocardial infarction, Biomaterials, 160, 69, 10.1016/j.biomaterials.2018.01.021 · DOI · Paper page
  16. Maghin, 2020, Young at Heart, Combining Strategies to Rejuvenate Endogenous Mechanisms of Cardiac Repair, Front. Bioeng. Biotechnol., 8, 447, 10.3389/fbioe.2020.00447 · DOI
  17. Carvalho, 2015, Myocardial infarction, stem cell transplantation for cardiac regeneration, Regen. Med., 10, 1025, 10.2217/rme.15.63 · DOI
  18. Karantalis, 2015, Use of mesenchymal stem cells for therapy of cardiac disease, Circ. Res., 116, 1413, 10.1161/CIRCRESAHA.116.303614 · DOI · Paper page
  19. Shafei, 2017, Mesenchymal stem cell therapy, A promising cellbased therapy for treatment of myocardial infarction, J. Gene Med., 19, e2995, 10.1002/jgm.2995 · DOI · Paper page
  20. Katarzyna, 2017, Adult stem cell therapy for cardiac repair in patients after acute myocardial infarction leading to ischemic heart failure, an overview of evidence from the recent clinical trials, Curr. Cardiol. Rev., 13, 223, 10.2174/1573403X13666170502103833 · doi:10.2174/1573403x13666170502103833
  21. Bar, 2020, Inducing Endogenous Cardiac Regeneration, Can Biomaterials Connect the Dots?, Front. Bioeng. Biotechnol., 8, 126, 10.3389/fbioe.2020.00126 · DOI
  22. Domenech, 2016, Tissue engineering strategies for myocardial regeneration, acellular versus cellular scaffolds?, Tissue Eng. Part B Rev., 22, 438, 10.1089/ten.teb.2015.0523 · DOI
  23. Ashtari, 2019, Electrically conductive nanomaterials for cardiac tissue engineering, Adv. Drug Deliv. Rev., 144, 162, 10.1016/j.addr.2019.06.001 · DOI · Paper page
  24. Saghazadeh, 2018, Drug delivery systems and materials for wound healing applications, Adv. Drug Deliv. Rev., 127, 138, 10.1016/j.addr.2018.04.008 · DOI · Paper page
  25. Wang, 2017, Novel biomaterial strategies for controlled growth factor delivery for biomedical applications, NPG Asia Mater., 9, e435, 10.1038/am.2017.171 · DOI · Paper page
  26. Kakkar, 2017, Evolution of macromolecular complexity in drug delivery systems, Nat. Rev. Chem., 1, 1, 10.1038/s41570-017-0063 · DOI · Paper page
  27. Mansurov, 2018, A controlled release system for simultaneous delivery of three human perivascular stem cell-derived factors for tissue repair and regeneration, J. Tissue Eng. Regen. Med., 12, e1164, 10.1002/term.2451 · DOI
  28. Jimi, 2020, Sequential Delivery of Cryogel Released Growth Factors and Cytokines Accelerates Wound Healing and Improves Tissue Regeneration, Front. Bioeng. Biotechnol., 8, 345, 10.3389/fbioe.2020.00345 · DOI
  29. Sultankulov, B., Berillo, D., Kauanova, S., Mikhalovsky, S., Mikhalovska, L., and Saparov, A. (2019). Composite Cryogel with Polyelectrolyte Complexes for Growth Factor Delivery. Pharmaceutics, 11. · DOI
  30. Sultankulov, B., Berillo, D., Sultankulova, K., Tokay, T., and Saparov, A. (2019). Progress in the Development of Chitosan-Based Biomaterials for Tissue Engineering and Regenerative Medicine. Biomolecules, 9. · doi:10.3390/biom9090470
  31. Jo, 2020, Influence of PEG chain length on colloidal stability of mPEGylated polycation based coacersomes for therapeutic protein delivery, J. Ind. Eng. Chem., 82, 234, 10.1016/j.jiec.2019.10.018 · DOI
  32. Li, 2016, Designing hydrogels for controlled drug delivery, Nat. Rev. Mater., 1, 1, 10.1038/natrevmats.2016.71 · DOI · Paper page
  33. Carlini, 2019, Enzyme-responsive progelator cyclic peptides for minimally invasive delivery to the heart post-myocardial infarction, Nat. Commun., 10, 1, 10.1038/s41467-019-09587-y · DOI
  34. Matsumura, 2019, Intramyocardial injection of a fully synthetic hydrogel attenuates left ventricular remodeling post myocardial infarction, Biomaterials, 217, 119289, 10.1016/j.biomaterials.2019.119289 · DOI
  35. Blackburn, 2015, Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarction, Biomaterials, 39, 182, 10.1016/j.biomaterials.2014.11.004 · DOI
  36. Lister, 2016, How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction, Front. Bioeng. Biotechnol., 4, 62, 10.3389/fbioe.2016.00062 · DOI
  37. Li, H., Bao, M., and Nie, Y. (2020). Extracellular matrix-based biomaterials for cardiac regeneration and repair. Heart Fail. Rev. · DOI
  38. Firoozi, S., Pahlavan, S., Ghanian, M.H., Rabbani, S., Tavakol, S., Barekat, M., Yakhkeshi, S., Mahmoudi, E., Soleymani, M., and Baharvand, H. (2020). A Cell-Free SDKP-Conjugated Self-Assembling Peptide Hydrogel Sufficient for Improvement of Myocardial Infarction. Biomolecules, 10. · DOI
  39. Cui, 2018, Polypyrrole-chitosan conductive biomaterial synchronizes cardiomyocyte contraction and improves myocardial electrical impulse propagation, Theranostics, 8, 2752, 10.7150/thno.22599 · DOI · Paper page
  40. Thiagarajan, 2017, Angiogenic growth factors in myocardial infarction, a critical appraisal, Heart Fail. Rev., 22, 665, 10.1007/s10741-017-9630-7 · DOI
  41. Frangogiannis, 2017, The extracellular matrix in myocardial injury, repair, and remodeling, J. Clin. Investig., 127, 1600, 10.1172/JCI87491 · DOI · Paper page
  42. Chen, 2019, Macrophage Smad3 protects the infarcted heart, stimulating phagocytosis and regulating inflammation, Circ. Res., 125, 55, 10.1161/CIRCRESAHA.119.315069 · DOI · Paper page
  43. Yue, 2020, Interleukin-10 Deficiency Alters Endothelial Progenitor Cell–Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment, Circ. Res., 126, 315, 10.1161/CIRCRESAHA.119.315829 · DOI · Paper page
  44. Jung, 2017, IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation, Basic Res. Cardiol., 112, 33, 10.1007/s00395-017-0622-5 · DOI · Paper page
  45. Ferraro, 2019, Pro-angiogenic macrophage phenotype to promote myocardial repair, J. Am. Coll. Cardiol., 73, 2990, 10.1016/j.jacc.2019.03.503 · DOI · Paper page
  46. Cahill, 2017, Heart regeneration and repair after myocardial infarction, translational opportunities for novel therapeutics, Nat. Rev. Drug Discov., 16, 699, 10.1038/nrd.2017.106 · DOI · Paper page
  47. Shiraishi, 2016, Alternatively activated macrophages determine repair of the infarcted adult murine heart, J. Clin. Investig., 126, 2151, 10.1172/JCI85782 · DOI · Paper page
  48. Oduk, 2018, VEGF nanoparticles repair the heart after myocardial infarction, Am. J. Physiol.-Heart C, 314, H278, 10.1152/ajpheart.00471.2017 · DOI
  49. Hachim, 2019, Glycosaminoglycan-based biomaterials for growth factor and cytokine delivery: Making the right choices, J. Control. Release, 313, 131, 10.1016/j.jconrel.2019.10.018 · DOI
  50. Shi, 2019, Heparan sulfate proteoglycan promotes fibroblast growth factor-2 function for ischemic heart repair, Biomater. Sci., 7, 5438, 10.1039/C9BM01336A · DOI
  51. Fan, 2019, Myocardial-Infarction-Responsive Smart Hydrogels Targeting Matrix Metalloproteinase for On-Demand Growth Factor Delivery, Adv. Mater., 31, 1902900, 10.1002/adma.201902900 · DOI · Paper page
  52. Itoh, 2016, Roles of FGF signals in heart development, health, and disease, Front. Cell Dev. Biol., 4, 110
  53. Teringova, 2017, Apoptosis in ischemic heart disease, J. Transl. Med., 15, 87, 10.1186/s12967-017-1191-y · DOI · Paper page
  54. Awada, 2015, Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction, J. Control. Release, 207, 7, 10.1016/j.jconrel.2015.03.034 · DOI · Paper page
  55. Taimeh, 2013, Vascular endothelial growth factor in heart failure, Nat. Rev. Cardiol., 10, 519, 10.1038/nrcardio.2013.94 · DOI · Paper page
  56. Corti, 2017, Modulation of VEGF receptor 2 signaling by protein phosphatases, Pharmacol. Res., 115, 107, 10.1016/j.phrs.2016.11.022 · DOI
  57. Cassani, 2020, Combining Nanomaterials and Developmental Pathways to Design New Treatments for Cardiac Regeneration, The Pulsing Heart of Advanced Therapies, Front. Bioeng. Biotechnol., 8, 323, 10.3389/fbioe.2020.00323 · DOI
  58. Catoira, 2019, Overview of natural hydrogels for regenerative medicine applications, J. Mater. Sci. Mater. Med., 30, 115, 10.1007/s10856-019-6318-7 · DOI · Paper page
  59. Gyles, 2017, A review of the designs and prominent biomedical advances of natural and synthetic hydrogel formulations, Eur. Polym. J., 88, 373, 10.1016/j.eurpolymj.2017.01.027 · DOI · Paper page
  60. Rufaihah, 2017, Angiogenic peptide nanofibers repair cardiac tissue defect after myocardial infarction, Acta Biomater., 58, 102, 10.1016/j.actbio.2017.06.009 · DOI
  61. Navaei, 2016, PNIPAAm-based biohybrid injectable hydrogel for cardiac tissue engineering, Acta Biomater., 32, 10, 10.1016/j.actbio.2015.12.019 · DOI
  62. Yuan, 2019, Injectable citrate-based hydrogel as an angiogenic biomaterial improves cardiac repair after myocardial infarction, ACS Appl. Mater. Interfaces, 11, 38429, 10.1021/acsami.9b12043 · DOI
  63. Waters, 2018, Stem cell-inspired secretome-rich injectable hydrogel to repair injured cardiac tissue, Acta Biomater., 69, 95, 10.1016/j.actbio.2017.12.025 · DOI · Paper page
  64. Ho, 2016, Nanoparticle drug delivery systems and their use in cardiac tissue therapy, Nanomedicine, 11, 693, 10.2217/nnm.16.6 · DOI
  65. Nguyen, 2015, Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial Infarction, Adv. Mater., 27, 5547, 10.1002/adma.201502003 · DOI · Paper page
  66. Somasuntharam, 2016, Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction, Biomaterials, 83, 12, 10.1016/j.biomaterials.2015.12.022 · DOI
  67. Qi, 2017, Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction, Int. J. Nanomed., 12, 4835, 10.2147/IJN.S132064 · DOI
  68. Steele, 2020, Multi-phase catheter-injectable hydrogel enables dual-stage protein-engineered cytokine release to mitigate adverse left ventricular remodeling following myocardial infarction in a small animal model and a large animal model, Cytokine, 127, 154974, 10.1016/j.cyto.2019.154974 · DOI
  69. Park, 2019, Cardiac fibrosis, potential therapeutic targets, Transl. Res., 209, 121, 10.1016/j.trsl.2019.03.001 · DOI · Paper page
  70. Lin, 2019, A viscoelastic adhesive epicardial patch for treating myocardial infarction, Nat. Biomed. Eng., 3, 632, 10.1038/s41551-019-0380-9 · DOI · Paper page
  71. Wan, 2017, Human heart valve-derived scaffold improves cardiac repair in a murine model of myocardial infarction, Sci. Rep., 7, 1
  72. Fan, 2020, CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice, J. Mol. Cell. Cardiol., 141, 1, 10.1016/j.yjmcc.2020.03.003 · DOI
  73. Donndorf, 2013, Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease, Curr. Pharm. Biotechnol., 14, 12
  74. Saparov, 2013, The role of antioxidation and immunomodulation in postnatal multipotent stem cell-mediated cardiac repair, Int. J. Mol. Sci., 14, 16258, 10.3390/ijms140816258 · DOI
  75. Luo, 2017, Fabrication of synthetic mesenchymal stem cells for the treatment of acute myocardial infarction in mice, Circ. Res., 120, 1768, 10.1161/CIRCRESAHA.116.310374 · DOI · Paper page
  76. Chang, M.L., Chiu, Y.J., Li, J.S., Cheah, K.P., and Lin, H.H. (2020). Analyzing Impetus of Regenerative Cellular Therapeutics in Myocardial Infarction. J. Clin. Med., 9. · doi:10.3390/jcm9051277
  77. Chen, 2013, Human pericytes for ischemic heart repair, Stem cells, 31, 305, 10.1002/stem.1285 · DOI · Paper page
  78. Jiang, 2020, Heart regeneration with human pluripotent stem cells, Prospects and challenges, Bioact. Mater., 5, 74
  79. Parizadeh, 2019, Stem cell therapy, A novel approach for myocardial infarction, J. Cell. Physiol., 234, 16904, 10.1002/jcp.28381 · DOI
  80. Higuchi, 2017, Stem cell therapies for myocardial infarction in clinical trials, bioengineering and biomaterial aspects, Lab. Investig., 97, 1167, 10.1038/labinvest.2017.100 · DOI
  81. Karantalis, 2014, Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting, the Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial, Circ. Res., 114, 1302, 10.1161/CIRCRESAHA.114.303180 · DOI · Paper page
  82. Luger, 2017, Intravenously delivered mesenchymal stem cells, systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy, Circ. Res., 120, 1598, 10.1161/CIRCRESAHA.117.310599 · DOI · Paper page
  83. Bao, 2017, C-Kit Positive cardiac stem cells and bone marrow–derived mesenchymal stem cells synergistically enhance angiogenesis and improve cardiac function after myocardial infarction in a paracrine manner, J. Card. Fail., 23, 403, 10.1016/j.cardfail.2017.03.002 · DOI
  84. Kanda, 2017, Cellular mechanisms underlying cardiac engraftment of stem cells, Expert Opin. Biol. Ther., 17, 1127, 10.1080/14712598.2017.1346080 · DOI
  85. Yao, 2018, Potentials of combining nanomaterials and stem cell therapy in myocardial repair, Nanomedicine (Lond), 13, 1623, 10.2217/nnm-2018-0013 · DOI
  86. Amer, 2016, A detailed assessment of varying ejection rate on delivery efficiency of mesenchymal stem cells using narrow-bore needles, Stem cells Transl. Med., 5, 366, 10.5966/sctm.2015-0208 · DOI
  87. Aguado, 2012, Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers, Tissue Eng. Part A, 18, 806, 10.1089/ten.tea.2011.0391 · DOI · Paper page
  88. Park, 2020, Stem cell-loaded adhesive immiscible liquid for regeneration of myocardial infarction, J. Control. Release, 321, 602, 10.1016/j.jconrel.2020.02.047 · DOI
  89. Chen, 2020, Tailorable Hydrogel Improves Retention and Cardioprotection of Intramyocardial Transplanted Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice, J. Am. Heart Assoc., 9, e013784, 10.1161/JAHA.119.013784 · DOI
  90. Blocki, 2015, Microcapsules engineered to support mesenchymal stem cell (MSC) survival and proliferation enable long-term retention of MSCs in infarcted myocardium, Biomaterials, 53, 12, 10.1016/j.biomaterials.2015.02.075 · DOI
  91. Gallagher, 2020, Pre-culture of mesenchymal stem cells within RGD-modified hyaluronic acid hydrogel improves their resilience to ischaemic conditions, Acta Biomater., 107, 78, 10.1016/j.actbio.2020.02.043 · DOI
  92. Chow, 2017, Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Encapsulating Bioactive Hydrogels Improve Rat Heart Function Post Myocardial Infarction, Stem Cell Rep., 9, 1415, 10.1016/j.stemcr.2017.09.003 · DOI
  93. Cai, 2019, Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction, Faseb J., 33, 8306, 10.1096/fj.201801768RR · DOI
  94. Harel, 2017, NOX2, NOX4, and mitochondrial-derived reactive oxygen species contribute to angiopoietin-1 signaling and angiogenic responses in endothelial cells, Vasc. Pharm., 92, 22, 10.1016/j.vph.2017.03.002 · DOI
  95. Lee, 2018, Prolonged survival of transplanted stem cells after ischaemic injury via the slow release of pro-survival peptides from a collagen matrix, Nat. Biomed. Eng., 2, 104, 10.1038/s41551-018-0191-4 · DOI
  96. Ottersbach, 2018, Improved heart repair upon myocardial infarction, Combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytes, Biomaterials, 155, 176, 10.1016/j.biomaterials.2017.11.012 · DOI
  97. Choe, 2019, Anti-oxidant activity reinforced reduced graphene oxide/alginate microgels, Mesenchymal stem cell encapsulation and regeneration of infarcted hearts, Biomaterials, 225, 119513, 10.1016/j.biomaterials.2019.119513 · DOI · Paper page
  98. Kai, 2014, Stem cell-loaded nanofibrous patch promotes the regeneration of infarcted myocardium with functional improvement in rat model, Acta. Biomater., 10, 2727, 10.1016/j.actbio.2014.02.030 · DOI
  99. Wang, 2017, Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium, J. Cell Mol. Med., 21, 1751, 10.1111/jcmm.13097 · DOI
  100. Chen, 2018, Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats, Acta. Biomater., 80, 154, 10.1016/j.actbio.2018.09.013 · DOI · Paper page
  101. Gaetani, 2015, Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarction, Biomaterials, 61, 339, 10.1016/j.biomaterials.2015.05.005 · DOI · Paper page
  102. Su, 2018, Cardiac Stem Cell Patch Integrated with Microengineered Blood Vessels Promotes Cardiomyocyte Proliferation and Neovascularization after Acute Myocardial Infarction, ACS Appl. Mater. Interfaces, 10, 33088, 10.1021/acsami.8b13571 · DOI
  103. Dong, 2020, Engineered bioactive nanoparticles incorporated biofunctionalized ECM/silk proteins based cardiac patches combined with MSCs for the repair of myocardial infarction, In vitro and in vivo evaluations, Sci. Total Environ., 707, 135976, 10.1016/j.scitotenv.2019.135976 · DOI
  104. Gao, 2017, Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold, Circ. Res., 120, 1318, 10.1161/CIRCRESAHA.116.310277 · DOI · Paper page
  105. Tang, 2018, Cardiac cell-integrated microneedle patch for treating myocardial infarction, Sci. Adv., 4, eaat9365, 10.1126/sciadv.aat9365 · DOI · Paper page
  106. Park, 2019, Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction, Nat. Commun., 10, 3123, 10.1038/s41467-019-11091-2 · DOI · Paper page
  107. Yeung, 2019, Cardiac regeneration using human-induced pluripotent stem cell-derived biomaterial-free 3D-bioprinted cardiac patch in vivo, J. Tissue Eng. Regen. Med., 13, 2031, 10.1002/term.2954 · DOI
  108. Melhem, 2017, 3D Printed Stem-Cell-Laden, Microchanneled Hydrogel Patch for the Enhanced Release of Cell-Secreting Factors and Treatment of Myocardial Infarctions, ACS Biomater. Sci. Eng., 3, 1980, 10.1021/acsbiomaterials.6b00176 · DOI
  109. Mayfield, 2014, The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function, Biomaterials, 35, 133, 10.1016/j.biomaterials.2013.09.085 · DOI
  110. Ahmadi, 2015, PET imaging of a collagen matrix reveals its effective injection and targeted retention in a mouse model of myocardial infarction, Biomaterials, 49, 18, 10.1016/j.biomaterials.2015.01.016 · doi:10.1016/j.biomaterials.2015.01.016
  111. Han, 2015, Iron oxide nanoparticle-mediated development of cellular gap junction crosstalk to improve mesenchymal stem cells’ therapeutic efficacy for myocardial infarction, ACS Nano, 9, 2805, 10.1021/nn506732n · DOI
  112. Lemcke, 2017, Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells, Sci. Rep., 7, 9755, 10.1038/s41598-017-10122-6 · doi:10.1038/s41598-017-10122-6
  113. Marcu, 2015, Functional Characterization and Comparison of Intercellular Communication in Stem Cell-Derived Cardiomyocytes, Stem Cells, 33, 2208, 10.1002/stem.2009 · DOI
  114. Sottas, 2018, Improving electrical properties of iPSC-cardiomyocytes by enhancing Cx43 expression, J. Mol. Cell Cardiol., 120, 31, 10.1016/j.yjmcc.2018.05.010 · DOI
  115. Liang, 2019, Conductive Hydrogen Sulfide-Releasing Hydrogel Encapsulating ADSCs for Myocardial Infarction Treatment, ACS Appl. Mater. Interfaces, 11, 14619, 10.1021/acsami.9b01886 · DOI
  116. Tang, 2018, Targeted repair of heart injury by stem cells fused with platelet nanovesicles, Nat. Biomed. Eng., 2, 17, 10.1038/s41551-017-0182-x · DOI · Paper page
  117. Yokoyama, 2019, Cardiac Regeneration by Statin-Polymer Nanoparticle-Loaded Adipose-Derived Stem Cell Therapy in Myocardial Infarction, Stem Cells Transl. Med., 8, 1055, 10.1002/sctm.18-0244 · DOI
  118. Yao, 2015, Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction, Biomaterials, 60, 130, 10.1016/j.biomaterials.2015.04.046 · DOI · Paper page
  119. Saludas, 2017, Transplantation of adipose-derived stem cells combined with neuregulin-microparticles promotes efficient cardiac repair in a rat myocardial infarction model, J. Control. Release, 249, 23, 10.1016/j.jconrel.2017.01.026 · DOI
  120. Chung, 2015, Epicardial delivery of VEGF and cardiac stem cells guided by 3-dimensional PLLA mat enhancing cardiac regeneration and angiogenesis in acute myocardial infarction, J. Control. Release, 205, 218, 10.1016/j.jconrel.2015.02.013 · DOI
  121. Kumar, 2016, Animal models of myocardial infarction, mainstay in clinical translation, Regul. Toxicol. Pharmacol., 76, 221, 10.1016/j.yrtph.2016.03.005 · DOI
  122. Zaragoza, 2011, Animal models of cardiovascular diseases, J. Biomed. Biotechnol., 2011, 497841, 10.1155/2011/497841 · DOI · Paper page
  123. Seyhan, 2019, Lost in translation, the valley of death across preclinical and clinical divide–identification of problems and overcoming obstacles, Transl. Med. Commun., 4, 1, 10.1186/s41231-019-0050-7 · DOI · Paper page
  124. Camacho, 2016, Small mammalian animal models of heart disease, Am. J. Cardiovasc. Dis., 6, 70

Cited by

See all 64

Metadata

Authors
Smagul, S., Kim, Y., Smagulova, A., Raziyeva, K., Nurkesh, A., & Saparov, A.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-08-19
Volume
21
Issue
17
Pages
5952
ISSN
1422-0067
Cited by
64
References
4
Language
en
Funders
Ministry of Education and Science (АР05135207)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biomaterials Loaded with Growth Factors/Cytokines and Stem Cells for Cardiac Tissue Regeneration. https://app.cochat.ai/papers/10.3390/ijms21175952
The paper
Smagul, S., Kim, Y., Smagulova, A., Raziyeva, K., Nurkesh, A., & Saparov, A. (2020). Biomaterials Loaded with Growth Factors/Cytokines and Stem Cells for Cardiac Tissue Regeneration. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21175952

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.